News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP programmes and uptake news

Show

From To
PrEP programmes and uptake
Study illuminates PrEP treatment pathway and its facilitators and barriers for women in the Bronx

Self-perceived HIV risk, learning about pre-exposure prophylaxis (PrEP) via trusted sources, positive healthcare experiences and health insurance coverage are facilitators of PrEP initiation and continuation for at-risk minority

Published
17 June 2019
By
Michael Carter
PrEP programmes and uptake
My PrEP Story: KUCHENGA (part 2)

When a friend stays over, I notice the flash glance in the morning as I dole out my PrEP meds, hormones and vitamins from my divider and down them with citrus juice. Silence doesn’t ‘always’ speak volumes but in this case it does.

Published
11 June 2019
From
Prepster
Access to medicines and treatment
This drug could end HIV. Why hasn't it? (Podcast)

Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened.

Published
06 June 2019
From
New York Times
Structural factors
Gay men in PROUD trial experienced high rates of intimate partner violence

Screening for intimate partner violence should form part of sexual health services to reach vulnerable gay men.

Published
03 June 2019
From
Avert
PrEP programmes and uptake
UK's biggest sexual health clinic has just dropped its PrEP prices

PrEP has become more affordable at London’s leading sexual health clinic. The 56 Dean Street clinic opened its PrEP Shop in February last year and provides the HIV preventative medication for those eligible for NHS care. It will cost as little as £17.50 per month.

Published
02 June 2019
From
Gay Star News
Combatting stigma
Q&A: Battling HIV PrEP stigma with Rep. Brian Sims

To combat the stigma surrounding PrEP use, Pennsylvania state Rep. Brian Sims, D-Philadelphia, the first openly gay man to be elected to the Pennsylvania legislature, recently shared a photo of himself holding an FTC/TDF pill on Instagram.

Published
24 May 2019
From
Healio
PrEP programmes and uptake
Being black and gay: how intersectional stigma impacts on the uptake of PrEP

Qualitative research published in the July issue of Social Science & Medicine by Dr Katherine Quinn and colleagues at the Center for AIDS Intervention Research highlights how

Published
17 May 2019
By
Krishen Samuel
Pharmaceutical industry
A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

A donation of H.I.V.-prevention drugs from the pharmaceutical giant Gilead could benefit shareholders more than patients.

Published
14 May 2019
From
The New York Times (editorial)
PrEP programmes and uptake
Generic HIV prevention drug coming in 2020, Gilead says

"Gilead reached an agreement with Teva Pharmaceuticals in 2014 to allow the early launch of a generic version of Truvada into the market in 2020, a year earlier than required," wrote Douglas Brooks, Gilead's executive director for community engagement, in an email shared with NBC News by the advocacy group PrEP4All.

Published
09 May 2019
From
CNBC
PrEP programmes and uptake
Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

While Gilead’s announcement that generic Truvada will be made available in the United States a year early is a victory for the LGBTQ+ community, for HIV activists, and for U.S. taxpayers, this should only be the beginning. Even their announcement today leaves Gilead with exclusive rights to Truvada as PrEP for another 15 months and Teva as the only generic manufacturer on the U.S. market. This will do little to reduce the price in a way that will increase access and PrEP4All remains suspicious of the terms and lack of transparency surrounding the Teva settlement.

Published
09 May 2019
From
Breakthepatent.org
← Prev12345...16Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.